chrisvoncsefalvay/vaers-outcomes huggingface dataset:
get so sick from the shots; feel like whole body was toxic; Initial information received on 07-Dec-2020 regarding an unsolicited valid non-serious social media case received from a non-healthcare professional (patient).    This case involves a patient of an unknown demographic who get so sick from the shots (Illness) and feel like whole body was toxic (Feeling abnormal), after receiving INFLUENZA VACCINE.  Medical history, medical treatments, vaccinations, concomitant medications and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiry date not reported) via an unknown route in unknown administration site.   On an unknown date, (unknown latency) it was reported that get so sick from the shots. Feel like whole body was toxic. Never again do want to put toxins in body and feel that way.  No relevant laboratory details were provided.  It was not reported if the patient received a corrective treatment.  Outcome was reported as unknown, at the time of reporting.  There will be no information available on the batch number for this case.
afterward, normal marginally sore arm; left armpit became tender and started hurting (there was no lymph-node type lump that could palpate; The injection site bled at the time of injection; This is a spontaneous report from a contactable consumer (patient). A 45-years-old female patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection), dose 2 intramuscular, administered in Arm Left on 09May2021 13:30 (at the age of 45-years-old) (Batch/Lot Number: EW0182) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history was none. Concomitant medication included multivitamin (within 2 weeks of vaccination). Patient had no allergies. The patient had not received any other vaccine within 4 weeks. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. Patient previously took first dose of bnt162b2 (Lot number: EW0164) administered in Arm right on 18Apr2021 at 12:30PM (at the age of 45-years-old), Intramuscular for covid-19 immunisation. On 09May2021, the patient experienced the injection site bled at the time of injection, afterward, on 10May2021 16:00, normal marginally sore arm, around 24h after the injection and left armpit became tender and started hurting (there was no lymph-node type lump that could palpate). Patient received no treatment for the events. It was reported that the patient was not hospitalized. Seriousness of events were reported as non serious by the reporter. Outcome of events were recovering.   No follow-up attempts are needed. No further information is expected.
PT COULDNT COME FOR SECOND DOSE BECAUSE HE TESTED POSTIVE FOR COVID  HE RECIEVED FIRST DOSE 03/23/21  AND PRESENTED SYMPTOMS ON 04/07 WITH CONFIRMED CASE ON 04/09/21
Very dizzy; Hearing problem; sick; This is a spontaneous report from a contactable consumer (patient). A 74-years-old patient of an unspecified gender received first dose of bnt162b2 (formulation: Solution for injection, Batch/Lot Number: EW0153) via an unspecified route of administration, administered in Arm on 24May2021 16:40 (at the age of 74- years-old) as 1ST DOSE, SINGLE DOSE for covid-19 immunisation. Medical history included hypertension and thyroid disorder which was surgically removed (thyroidectomy). Family medical history related to adverse event (dizziness), the patient reported yes, but most of the family was dead but don't think that really matter. The patient's concomitant medications include one for thyroid (not clarified further) and had never taken any medicine. The patient did not receive any other vaccine 4 weeks prior to COVID 19 Vaccine probably since 1993 and never got sick. On an unspecified date, the patient was very dizzy for over a week and didn't even think to call doctor, but did today, because patient would take the second shot on Monday (14Jun 2021). The doctor would give the patient medication if got dizzy again. The patient had lab test coming up, which are yearly test that I get because I don't have a thyroid. The patient also had hearing problem on an unknown date. The patient never got sick but covid 19 vaccine made sick. The patient did not receive treatment for the events. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
I received the first vaccine on Feb 3rd.  On Feb 22nd I took a precautionary COVID pcr test.  I didn?t have any symptoms, just took the test because we were on vacation the week prior and I was getting my kids tested to go back to school next week.  I was very surprised my test came back positive but all 3 of my children and my husband came back negative.  We had been in close quarters all together in the same house since the kids were on break.  I am a symptomatic,  so we are following the doctors protocol for quarantining.   Since the vaccines are still being studied, I wanted to make sure I share this info?
Fever 103 F, pain, swelling, redness, hot to touch, abdominal pain. Went to urgent care, examined by her PCP, labs drawn, received Tylenol for fever. PCP prescribed antibiotics if fever returns. Client reports not taking any antibiotic. Client reports site feels and looks better today.
rash; itching; red; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash), PAIN IN EXTREMITY (sore arm), PRURITUS (itching) and ERYTHEMA (red) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (allergy to sulfur). Concomitant products included METOPROLOL TARTRATE for Hypertension, LEVOTHYROXINE SODIUM for Hypothyroidism, GABAPENTIN (NEURONTIN), MECLIZINE HCL and ALPRAZOLAM for an unknown indication.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 31-Mar-2021, the patient experienced RASH (rash), PRURITUS (itching) and ERYTHEMA (red). At the time of the report, RASH (rash), PAIN IN EXTREMITY (sore arm), PRURITUS (itching) and ERYTHEMA (red) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details include antihistamine.   This case was linked to MOD21-066716 (Patient Link).
LOCAL ERYTHEMA/INDURATION AT VACCINE SITE MEASURING 50mm BY 70mm. LOCAL TENDERNESS,PAIN. ONSET EVENING AFTER INJECTION RECEIVED 12/9/03 PRESENT STILL AM 12/11/03.
Patient reported an injection site reaction; swelling, increased temperature, and redness at the site of injection.
Report received from a PharmD on 27-Oct-2008.  An employee received AFLUIA (CSL influenza vaccine, date of administration unknown).  At unknown time after administration, the patient developed localized reaction at the injection site 2-4 inches in diameter.  The site was red and circular, warm, and puffy.  The employee received a prefilled syringe.  (The report concerned two patients.  For other patient, see case 200814227).  Additional information has been requested.  No serious criteria mentioned.  Causality: unassessable/ unclassifiable.  Follow-up information was received on 11-Nov-2008 from the PharmD.  Per the PharmD, he will not be providing any additional details as he discussed the case with the hospital nurse and they decided the events were within the expected and listed ADRs.   No change in assessment.  Information derived from this AE report does not change the current safety profile of AFLURIA (FLUVAX).
Patient reports sudden change in vision and "zapping " sensation in brain as well as short term memory loss that started within 1 week of vaccination and is progressively worsening
This case was reported by a pharmacist via call center representative and described the occurrence of injection site tenderness in a 73-year-old female patient who received SHINGRIX (batch number T5242, expiry date 3rd March 2020). On 5th April 2018, the patient received SHINGRIX. In April 2018, less than a day after receiving SHINGRIX, the patient experienced injection site tenderness, injection site erythema, malaise and fatigue. On an unknown date, the outcome of the injection site tenderness, injection site erythema, malaise and fatigue were unknown. The reporter considered the injection site tenderness, injection site erythema, malaise and fatigue to be probably related to SHINGRIX. Additional details were provided as follows: The reporting pharmacist did not want to give medication or medical history during call. Within 24 hours of receiving SHINGRIX in the left arm, the patient experienced malaise, fatigue, redness at the injection site and tenderness at the injection site. The reporting pharmacist stated that she had spoken to patient twice since the patient received the vaccine, and was not aware of any medical intervention taken. The reporting pharmacist stated this was very likely to have been caused by SHINGRIX. The reported lot number (T5252) for SHINGRIX did not exist and was updated to T5242, according to sales database.
Pt wife states that husband received twinrix and shingrix yesterday.  Last night, started complaining of headache.  Worsened today and had to leave work early.  Took ibuprofen.  Wife doesn't know if patient has any other symptoms.  I advised her to contact doctor if symptoms worsen or if he develops fever or swelling.
The arm is red and swollen. She went to see 2 different Dr. Pt said it may be cellulitis per Dr.
Headache; Fever; They felt like poo poo. They felt really bad; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 43 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: HEADACHE (non-serious), outcome "recovered", described as "Headache"; PYREXIA (non-serious), outcome "recovered", described as "Fever"; FEELING ABNORMAL (non-serious), outcome "recovered", described as "They felt like poo poo. They felt really bad". Patient had a headache and fever. The next morning, he felt like poo poo and felt really bad.  Follow-up (21Feb2022): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Weak; Collapsed; Delirium; Night sweats; Chills; Discomfort; Did not sleep at all that night; A spontaneous report was received from a physician, who was also an 80-year-old, male, patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced, chills, discomfort, night sweats, did not sleep at all, delirium, collapsed, and felt weak.   The patient's medical history, as provided by the reporter, included type II diabetes, diabetic neuropathy, heart failure, acid reflux, and urinary retention. Concomitant medications included metformin, gabapentin, furosemide, spironolactone, omeprazole, and tamsulosin.   On 06 Jan 2021, hours prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.   On the evening of 06 Jan 2021, hours after vaccination, the patient began feeling chills and discomfort. Overnight he began to experience night sweats and did not sleep at all.   During the night on 07 Jan 2021, the patient experienced night sweats and had delirium. When he tried to get out of bed, he collapsed. No treatment information was provided.   On 11 Jan 2021 and 12 Jan 2021, the patient began to feel better. He no longer had night sweats or delirium. He returned to his exercise routine at about 50 percent of what he normally did although he continued to feel weak.  Action taken with mRNA-1273 in response to the events was not provided, although the patient reported he was not sure if he would take the second dose.  The outcome for the events, night sweats and delirium, was considered resolved. The outcome for the events, chills, discomfort, did not sleep at all, and collapsed, was considered resolving. The event, weak, was considered not resolved.  The reporter assessed the events, chills, discomfort, night sweats, did not sleep at all, delirium, collapsed, and weak, as related to Moderna's COVID-19 vaccine due to feeling well before the vaccine and feeling more or less disabled after receiving it.; Reporter's Comments: This case concerns a 80-year-old, male subject with medical history of type II diabetes and diabetic neuropathy, who experienced a serious unexpected event of delirium and non-serious unexpected event of asthenia, discomfort, insomnia, fall, and night sweats, and non-serious expected event of chills. The event of discomfort, insomnia, chills and night sweats occurred 1 day; the event of delirium, and fall occurred 2 days and asthenia occurred 6 days after mRNA-1273 administration.  The subject was on metformin for diabetes ty II and gabapentin for diabetic neuropathy, Lasix and spironolactone for heart failure, omeprazole for acid reflux and Flomax for urinary retention. Treatment details not provided. Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Approximately 15 minutes after administration, pt c/o headache. Within 45 min to 1 hour after administration, pt c/o dizziness, chest pain/pressure, and shortness of breath. Pt was seen in emergency department. Pt was given NS 0.9% via IV; SOLU-MEDROL 125 mg IV; PEPCID 20mg IV; Diphenhydramine 25mg IV; Ketorolac 30 mg IV; Albuterol 2.5mg Inhalation. Pt was released home after treatment.
27 year with Covid-19 viral infection developed acute bronchitis, he is maintaining normal saturation on room air and lungs auscultation normal, no x-ray taken.  antibiotics, dexamethasone, MD decongestion and supportive care.  Advised monitor temperatures and oxygen
an internal vibrating tremor inside of her body; flu like symptoms; high blood pressure; insomnia; increase pulse; Dilated pupils; A spontaneous report was received from a healthcare professional concerning a 39-year-old, female patient who received Modern's COVID-19 vaccine (mRNA-1273) and experienced flu like symptoms, a feeling of an internal vibrating tremor inside of her body/tremor, high blood pressure/increased blood pressure, insomnia, dilated pupil/mydriasis and increase pulse/heart rate increased.  The patient's medical history was not provided. No relevant concomitant medications were reported.    On 24-Jan-2021, prior to the onset of the events, the patient received the second dose of two planned doses of mRNA-1273 (lot/batch: unknown)on left arm for prophylaxis of COVID-19 infection.  On 25-Jan-2021, The patient experienced flu like symptoms, but in the afternoon of the same day she also started to experience an internal "vibrating" tremor inside of her body.  She had this symptom for 4 weeks now along with high blood pressure, insomnia, dilated pupils and increase pulse. A neurologist told her that it could be an adrenergic hyper response to the vaccine.  No Laboratory details provided.  Treatment information provided was beta blockers prescribed in the ER visit.   Action taken with mRNA-1273 in response to the events is not applicable.   At the time of this report, the outcome of the events experienced flu like symptoms, a feeling of an internal vibrating tremor inside of her body, high blood pressure, insomnia, dilated pupil and increase pulse is Unknown.; Reporter's Comments: This case concerns a 39 Y/O F with a serious unexpected event of tremor and NS unexpected influenza like illness, blood pressure increased, heart rate increased, mydriasis, insomnia, and possibly a "adrenergic hyper response to the vaccine". Treated with beta blockers. Event onset 2 days after first dose mRNA-1273. Outcome unknown. Based on current available information and temporal association between use of the product and the start date of the event, a causal relationship cannot be excluded.
administered vaccination and was observing patient post,, after about 15 -20 minutes patient , patient said his throat was felling tight. He was able to speak but throat felt tight.
Felt horrible; Light headedness; body aches; elevated temperature no higher than 100.4; Fatigue; Body aches; Headaches; Vaccine exposure during pregnancy; after receiving the vaccine the patient started feeling unwell; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy), VACCINATION COMPLICATION (after receiving the vaccine the patient started feeling unwell), FEELING ABNORMAL (Felt horrible), DIZZINESS (Light headedness) and PAIN (body aches) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Asthma, Infertility and In vitro fertilization. Concurrent medical conditions included Down's syndrome.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 11-Jul-2021. On 26-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) and VACCINATION COMPLICATION (after receiving the vaccine the patient started feeling unwell). On 27-Jan-2021, the patient experienced FEELING ABNORMAL (Felt horrible), DIZZINESS (Light headedness), PAIN (body aches), PYREXIA (elevated temperature no higher than 100.4), FATIGUE (Fatigue), MYALGIA (Body aches) and HEADACHE (Headaches). On 26-Jan-2021, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) outcome was unknown. At the time of the report, VACCINATION COMPLICATION (after receiving the vaccine the patient started feeling unwell), FEELING ABNORMAL (Felt horrible), DIZZINESS (Light headedness), PAIN (body aches), PYREXIA (elevated temperature no higher than 100.4), FATIGUE (Fatigue), MYALGIA (Body aches) and HEADACHE (Headaches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Body temperature: high (High) elevated temperature no higher than 100.4.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Headache, gastrointestinal distress (diarrhea); swollen lips and eyelids; period started 2 weeks early
had a stroke; This case was reported by a consumer via interactive digital media and described the occurrence of stroke in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, 2 weeks after receiving Shingles vaccine, the patient experienced stroke (serious criteria GSK medically significant). On an unknown date, the outcome of the stroke was unknown.   It was unknown if the reporter considered the stroke to be related to Shingles vaccine.  Additional details were provided as follows: The case was self-reported by the patient. The age at vaccination was not reported. The patient stated that, he/she took a single vaccine and about 2 weeks later, had a stroke. The follow-up would not possible as no contact details were available.
arm is sore; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (arm is sore) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunization.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (arm is sore). At the time of the report, LIMB DISCOMFORT (arm is sore) outcome was unknown. Not Provided          No concomitant medications were provided No treatment medications were provided
DIARRHEA STARTED FRIDAY EVENING. LOOSE AT FIRST BUT BY 10/01/2013 IT BECAME WATERY. SAW DR. WHO BELIEVES WAS CAUSED BY VACCINES GIVEN 09/25/2013. HAD TO HAVE STOOL SAMPLE.
Pt received one dose of Flulaval which is indicated for adult use only.  Injection was given in left deltoid.  Per parent, patient did fine with no reactions.
On the 7th day after receiving the Moderna shot (dose #1) at approximately 11:00 pm while watching television, I suddenly started hearing loud cricket sounds that I thought were coming from outside.  Initially, I turned off the television then after a short period of time, I walked around the house, basement, and garage to see where the noise was coming from. After returning to bed, I turned off the television again, then realized the noise was coming from my ears!  Initially,  I was startled because there was nothing I could do and I could not fall to sleep.  In the morning, after thinking what had been different in my life, I remembered the vaccine.  I then researched and found that there had been others with the same or similar experience.  Diagnosis:  Tinnitus    On April 9th, I have an appointment with my Primary Care Manager, to discuss the situation.  I have a serious concern about taking the 2nd dose scheduled for Saturday, April 22.  Following my doctor's appointment, I will request an appointment with an Otolaryngologist.
Patient's arm started redness, swelling  and tenderness  after a few hours from vaccination. Patient was given ibuprofen for pain and inflammation.  Mum reports that patient is doing fine
EXPIRED VACCINE ADMINISTERED; This spontaneous report received from a pharmacist concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced expired vaccine administered. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of expired vaccine administered was not reported. This report was non-serious.